Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Brian Der-Hua Lu"'
Autor:
Ronald B. Langdon, Kumudu Pathiraja, James A. Knost, Siu Long Yao, Heinz-Josef Lenz, Brian Der-Hua Lu, Mansoor N. Saleh, Mary J. MacKenzie, Edward H. Lin
Publikováno v:
Cancer Medicine
Overexpression of insulin-like growth factor receptor type 1 (IGF-1R) may promote tumor development and progression in some cancer patients. Our objective was to assess tumor uptake of fluorodeoxyglucose by positron-emission tomography in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a634fb5eaa6d3c4b15acf80eafcc959
https://doi.org/10.1002/cam4.263
https://doi.org/10.1002/cam4.263
Autor:
Alvaro Lassaletta, Joseph Rubino, Michael Nebozhyn, Kumudu Pathiraja, Zsuzanna Pápai, Brian Der-Hua Lu, Richard Gorlick, Darcy A. Hille, Najat C. Daw, Odd R. Monge, Keith M. Skubitz, Stefan S. Bielack, Cynthia E. Herzog, Mark Ayers, David J. Mauro, Erica Boldrini, Peter M. Anderson, Siu Long Yao
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Pediatric Blood & Cancer
Consejería de Sanidad de la Comunidad de Madrid
Pediatric Blood & Cancer
Background Robatumumab (19D12; MK-7454 otherwise known as SCH717454) is a fully human antibody that binds to and inhibits insulin-like growth factor receptor-1 (IGF-1R). This multiinstitutional study (P04720) determined the safety and clinical effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ff23f29cb2e441ba8c22ae025c90df5
https://hdl.handle.net/20.500.12530/26021
https://hdl.handle.net/20.500.12530/26021
